SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-005343
Filing Date
2023-03-01
Accepted
2023-03-01 08:01:02
Documents
13
Period of Report
2023-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pmvp-20230301.htm   iXBRL 8-K 66227
2 EX-99.1 pmvp-ex99_1.htm EX-99 196247
  Complete submission text file 0000950170-23-005343.txt   393622

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pmvp-20230301_lab.xml EX-101.LAB 17012
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pmvp-20230301.xsd EX-101.SCH 2465
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pmvp-20230301_pre.xml EX-101.PRE 10667
7 EXTRACTED XBRL INSTANCE DOCUMENT pmvp-20230301_htm.xml XML 4525
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39539 | Film No.: 23689843
SIC: 2834 Pharmaceutical Preparations